Annals of Medicine
In the Clinical Pathology section of Annals of Medicine we consider for publication the latest advances in:
|Clinical and Translational Research in Laboratory Medicine||Clinical Chemistry||Clinical Haematology and Coagulation|
|Clinical Immunology and Autoimmunity||Clinical Microbiology||Laboratory Management|
|Molecular Diagnostics||Quality Assurance and Quality Management||Therapeutic Drug Monitoring and Clinical Toxicology|
|Validation of Biomarkers and New methodologies|
Annals of Medicine
Two-Year Impact Factor 3.243
Five-Year Impact Factor 3.840
Meet the Section Editor
Qing H Meng, PhD, MD, DABCC, FAACC, Department of Laboratory Medicine, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, USA
Dr Meng is Professor and Section Chief of the Clinical Chemistry Laboratories, Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center. He received his MD from China in 1985 and PhD in Medical Sciences from the University of Helsinki, Finland in 1999. Following postdoctoral training in Clinical Chemistry and McMaster University, he worked at the University of Saskatchewan and the Hospital for Sick Children, The University of Toronto. He has served with professional associations and organizations in numerous capacities and on is on a number of international journals' Editorial Boards. His current research interests include tumor biology, tumor biomarkers, cancer diagnostics and all aspects of clinical chemistry.
Why is Annals of Medicine the Best Publication for Your Research?
Fully open access, general medical journal publishing articles under a CC BY license, allowing maximum sharing and reuse of articles to our international readership;
Publishing all scientifically valid research, including reporting of negative and null data, from translational to clinical research in all disciplines and therapy areas;
Led by an international editorial team of subject experts who ensure a constructive and rigorous peer review process;
Your research is promoted via a tailored, multi-channel approach to maximize visibility, readership and impact.